Ophthalmic artery changes in type 2 diabetes with and without acute coronary syndrome

Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic hea...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 20; no. 1; pp. 512 - 10
Main Authors Wu, Lan-ting, Wang, Jia-lin, Wang, Yan-ling
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 05.11.2022
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.
AbstractList Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.
Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS).BACKGROUNDOcular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS).In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA.METHODSIn total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA.In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters.RESULTSIn this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters.This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.CONCLUSIONSThis study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.
Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.
Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). Methods In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. Results In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. Conclusions This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.
Abstract Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). Methods In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. Results In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. Conclusions This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.
Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). Methods In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. Results In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. Conclusions This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. Keywords: Acute coronary syndrome, Computational fluid dynamics, Hemodynamic numerical simulation, Ophthalmic artery, Type 2 diabetes
ArticleNumber 512
Audience Academic
Author Wang, Jia-lin
Wu, Lan-ting
Wang, Yan-ling
Author_xml – sequence: 1
  givenname: Lan-ting
  orcidid: 0000-0002-5990-5926
  surname: Wu
  fullname: Wu, Lan-ting
– sequence: 2
  givenname: Jia-lin
  orcidid: 0000-0001-7877-1620
  surname: Wang
  fullname: Wang, Jia-lin
– sequence: 3
  givenname: Yan-ling
  orcidid: 0000-0002-7191-6660
  surname: Wang
  fullname: Wang, Yan-ling
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36335387$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rHCEUhqWkNMm2f6AXZaA3vZnUj1HHm0II_QgEctNci6POrsusbtVpyb_v2d00zYZSBD0cn_Pq0fccncQUPUJvCb4gpBcfC6FKyBZT2mImCcwv0BnppGp5L8XJk_gUnZeyxph2vFOv0CkTjHHWyzN0d7td1ZWZNsE2Jlef7xu7MnHpSxNiU--3vqGNC2bwFVK_Ql01Jrp9kObaGDtX39iUUzRQWu6jy2njX6OXo5mKf_OwLtDdl8_fr761N7dfr68ub1rLBautlM5JbwyXnXFu6HrsBiwHhZUy48C6kUo5QM4o0hMhLew44pgcscCdEpQt0PVB1yWz1tscNnALnUzQ-0TKSw1NBTt5PXAllHcjIYZ21rCBdyAAx2BCu0H2oPXpoLWdh4131seazXQkerwTw0ov00-tBBOCcBD48CCQ04_Zl6o3oVg_TSb6NBdNJaOccYkZoO-foes05whPtaOk5D3p6V9qaaCBEMcE59qdqL6UlBOJe0WAuvgHBcN5-FRwzBggf1Tw7mmjjx3-MQUA9ADYnErJfnxECNY75-mD8zQ4T--dB_MC9c-KbKimhrR7rDD9r_Q3U87bqQ
CitedBy_id crossref_primary_10_3390_diagnostics13233514
crossref_primary_10_1002_jum_16598
Cites_doi 10.1155/2021/4946711
10.1111/j.1755-3768.2011.02178.x
10.1038/s41433-020-01173-7
10.1007/s10143-006-0028-6
10.1016/j.amjmed.2020.07.013
10.1007/s00417-014-2896-8
10.1016/j.ijbiomac.2020.01.168
10.1007/s001250051296
10.1111/jdi.12545
10.1016/S0140-6736(09)62124-3
10.1186/s12872-018-0806-4
10.1167/iovs.13-11763
10.1093/eurheartj/ehy822
10.1161/CIRCRESAHA.115.306301
10.3171/2019.5.FOCUS19234
10.1111/aos.12102
10.1016/j.exer.2015.12.011
10.1016/S0014-4835(02)00312-3
10.1016/j.exer.2006.03.024
10.1016/j.mvr.2009.12.007
10.1155/2018/7126532
10.2337/dc18-1390
10.1093/cvr/cvy174
10.4103/1793-5482.106643
10.1182/blood-2006-12-027698
10.1186/s12933-017-0534-6
10.1900/RDS.2012.9.104
10.1177/1479164118780799
10.3389/fcvm.2021.769343
10.1136/bjophthalmol-2013-304224
10.1016/j.jbiomech.2015.11.009
10.1186/s12933-018-0793-x
10.1002/ejhf.1359
10.1161/01.STR.22.6.711
10.1016/j.survophthal.2008.10.003
10.3390/ijms19061663
10.1016/j.bpj.2018.08.031
10.1186/s12933-018-0728-6
10.1001/jama.298.7.765
10.1167/iovs.62.14.7
10.3390/antiox11040617
10.4103/ijo.IJO_1398_19
10.1186/s12886-016-0217-1
10.1167/iovs.06-1280
10.1016/j.ophtha.2006.03.028
10.4103/JMU.JMU_88_20
10.1093/eurheartj/ehx810
10.1001/jamacardio.2016.2049
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12967-022-03712-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1479-5876
EndPage 10
ExternalDocumentID oai_doaj_org_article_b5969edf11a24ca3b54623afb0124b78
PMC9636615
A725170891
36335387
10_1186_s12967_022_03712_0
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
Beijing China
United States--US
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GrantInformation_xml – fundername: ;
  grantid: yyqdkt 2019-29
– fundername: ;
  grantid: No.81870686
– fundername: ;
  grantid: 202103
– fundername: ;
  grantid: No. 2018-1-2021
GroupedDBID ---
0R~
29L
2WC
53G
5VS
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-77dd7eaa574addb480db07b9099afb34f277b0dba918167cb90d1d37f06049623
IEDL.DBID M48
ISSN 1479-5876
IngestDate Wed Aug 27 01:26:09 EDT 2025
Thu Aug 21 18:39:50 EDT 2025
Fri Jul 11 03:17:47 EDT 2025
Fri Jul 25 06:08:09 EDT 2025
Tue Jun 17 21:34:09 EDT 2025
Tue Jun 10 20:25:41 EDT 2025
Thu Jan 02 22:55:16 EST 2025
Thu Apr 24 22:52:13 EDT 2025
Tue Jul 01 02:59:37 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Type 2 diabetes
Ophthalmic artery
Computational fluid dynamics
Acute coronary syndrome
Hemodynamic numerical simulation
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-77dd7eaa574addb480db07b9099afb34f277b0dba918167cb90d1d37f06049623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7191-6660
0000-0001-7877-1620
0000-0002-5990-5926
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12967-022-03712-0
PMID 36335387
PQID 2737758182
PQPubID 43076
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_b5969edf11a24ca3b54623afb0124b78
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9636615
proquest_miscellaneous_2732535703
proquest_journals_2737758182
gale_infotracmisc_A725170891
gale_infotracacademiconefile_A725170891
pubmed_primary_36335387
crossref_primary_10_1186_s12967_022_03712_0
crossref_citationtrail_10_1186_s12967_022_03712_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-11-05
PublicationDateYYYYMMDD 2022-11-05
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-05
  day: 05
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of translational medicine
PublicationTitleAlternate J Transl Med
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References T Zhang (3712_CR20) 2015; 253
V Kanagaraju (3712_CR10) 2021; 29
K Divya (3712_CR11) 2020; 68
F Molica (3712_CR30) 2018
TR Einarson (3712_CR1) 2018; 17
M Karami (3712_CR9) 2012; 9
J Raffort (3712_CR27) 2018; 114
SM Donahoe (3712_CR2) 2007; 298
N Dattani (3712_CR26) 2018; 15
J Lu (3712_CR48) 2019; 42
SP Jackson (3712_CR38) 2007; 109
L Chodari (3712_CR36) 2021; 2021
GM Rubanyi (3712_CR47) 1990; 27
C Sun (3712_CR8) 2009; 54
R Carpi-Santos (3712_CR33) 2022
D Arun (3712_CR28) 2021; 8
J Febina (3712_CR15) 2018; 2018
R Allon (3712_CR29) 2021; 134
G Franck (3712_CR41) 2019; 40
I Stalmans (3712_CR12) 2011; 89
K Polak (3712_CR24) 2003; 76
HY Chang (3712_CR39) 2018; 115
V Thondapu (3712_CR13) 2018; 39
MR Sterling (3712_CR49) 2018; 18
P Krasnicki (3712_CR5) 2014; 98
M Kojima (3712_CR17) 2012; 7
B Guerciotti (3712_CR14) 2016; 49
T von Hanno (3712_CR6) 2014; 92
M Zhou (3712_CR3) 2018; 17
X Luo (3712_CR25) 2015; 2015
LT Wu (3712_CR16) 2021; 62
G Querques (3712_CR44) 2021; 35
M Kanwar (3712_CR35) 2007; 48
R Rørth (3712_CR50) 2019; 21
R Klein (3712_CR22) 2006; 113
A Eftekhari (3712_CR31) 2020; 148
J Frösen (3712_CR46) 2019; 47
D Deng (3712_CR23) 1999; 42
N Cheung (3712_CR43) 2010; 376
A Eisen (3712_CR42) 2016; 1
Y Dong (3712_CR21) 2016; 16
T Tien (3712_CR32) 2013; 54
R Heitmar (3712_CR4) 2017; 16
T Tien (3712_CR7) 2016; 146
NASCE Trial (3712_CR18) 1991; 22
S Erdogmus (3712_CR19) 2006; 29
S Kralev (3712_CR45) 2010; 79
T Umemura (3712_CR37) 2017; 8
MA Gimbrone Jr (3712_CR40) 2016; 118
Y Cui (3712_CR34) 2006; 83
References_xml – volume: 2021
  start-page: 4946711
  year: 2021
  ident: 3712_CR36
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2021/4946711
– volume: 89
  start-page: e609
  year: 2011
  ident: 3712_CR12
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2011.02178.x
– volume: 35
  start-page: 142
  year: 2021
  ident: 3712_CR44
  publication-title: Eye
  doi: 10.1038/s41433-020-01173-7
– volume: 29
  start-page: 213
  year: 2006
  ident: 3712_CR19
  publication-title: Neurosurg Rev
  doi: 10.1007/s10143-006-0028-6
– volume: 134
  start-page: 36
  year: 2021
  ident: 3712_CR29
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2020.07.013
– volume: 253
  start-page: 627
  year: 2015
  ident: 3712_CR20
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-014-2896-8
– volume: 148
  start-page: 475
  year: 2020
  ident: 3712_CR31
  publication-title: Int J Biol Macromol
  doi: 10.1016/j.ijbiomac.2020.01.168
– volume: 42
  start-page: 1228
  year: 1999
  ident: 3712_CR23
  publication-title: Diabetologia
  doi: 10.1007/s001250051296
– volume: 8
  start-page: 134
  year: 2017
  ident: 3712_CR37
  publication-title: J Diabetes Investig
  doi: 10.1111/jdi.12545
– volume: 376
  start-page: 124
  year: 2010
  ident: 3712_CR43
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)62124-3
– volume: 2015
  year: 2015
  ident: 3712_CR25
  publication-title: J Ophthalmol
– volume: 18
  start-page: 66
  year: 2018
  ident: 3712_CR49
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-018-0806-4
– volume: 54
  start-page: 6518
  year: 2013
  ident: 3712_CR32
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.13-11763
– volume: 40
  start-page: 928
  year: 2019
  ident: 3712_CR41
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehy822
– volume: 118
  start-page: 620
  year: 2016
  ident: 3712_CR40
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.115.306301
– volume: 47
  start-page: E21
  year: 2019
  ident: 3712_CR46
  publication-title: Neurosurg Focus
  doi: 10.3171/2019.5.FOCUS19234
– volume: 92
  start-page: 40
  year: 2014
  ident: 3712_CR6
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.12102
– volume: 146
  start-page: 103
  year: 2016
  ident: 3712_CR7
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2015.12.011
– volume: 76
  start-page: 633
  year: 2003
  ident: 3712_CR24
  publication-title: Exp Eye Res
  doi: 10.1016/S0014-4835(02)00312-3
– volume: 83
  start-page: 807
  year: 2006
  ident: 3712_CR34
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2006.03.024
– volume: 79
  start-page: 150
  year: 2010
  ident: 3712_CR45
  publication-title: Microvasc Res
  doi: 10.1016/j.mvr.2009.12.007
– volume: 2018
  start-page: 7126532
  year: 2018
  ident: 3712_CR15
  publication-title: Comput Math Methods Med
  doi: 10.1155/2018/7126532
– volume: 42
  start-page: 1539
  year: 2019
  ident: 3712_CR48
  publication-title: Diabetes Care
  doi: 10.2337/dc18-1390
– volume: 114
  start-page: 1702
  year: 2018
  ident: 3712_CR27
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvy174
– volume: 7
  start-page: 159
  year: 2012
  ident: 3712_CR17
  publication-title: Asian J Neurosurg
  doi: 10.4103/1793-5482.106643
– volume: 109
  start-page: 5087
  year: 2007
  ident: 3712_CR38
  publication-title: Blood
  doi: 10.1182/blood-2006-12-027698
– volume: 16
  start-page: 56
  year: 2017
  ident: 3712_CR4
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-017-0534-6
– volume: 9
  start-page: 104
  year: 2012
  ident: 3712_CR9
  publication-title: Rev Diabet Stud
  doi: 10.1900/RDS.2012.9.104
– volume: 15
  start-page: 367
  year: 2018
  ident: 3712_CR26
  publication-title: Diab Vasc Dis Res
  doi: 10.1177/1479164118780799
– volume: 8
  year: 2021
  ident: 3712_CR28
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2021.769343
– volume: 98
  start-page: 675
  year: 2014
  ident: 3712_CR5
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2013-304224
– volume: 49
  start-page: 26
  year: 2016
  ident: 3712_CR14
  publication-title: J Biomech
  doi: 10.1016/j.jbiomech.2015.11.009
– volume: 17
  start-page: 147
  year: 2018
  ident: 3712_CR3
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-018-0793-x
– volume: 21
  start-page: 40
  year: 2019
  ident: 3712_CR50
  publication-title: Eur J Heart Fail
  doi: 10.1002/ejhf.1359
– volume: 22
  start-page: 711
  year: 1991
  ident: 3712_CR18
  publication-title: Stroke
  doi: 10.1161/01.STR.22.6.711
– volume: 54
  start-page: 74
  year: 2009
  ident: 3712_CR8
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2008.10.003
– year: 2018
  ident: 3712_CR30
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms19061663
– volume: 115
  start-page: 1371
  year: 2018
  ident: 3712_CR39
  publication-title: Biophys J
  doi: 10.1016/j.bpj.2018.08.031
– volume: 17
  start-page: 83
  year: 2018
  ident: 3712_CR1
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-018-0728-6
– volume: 298
  start-page: 765
  year: 2007
  ident: 3712_CR2
  publication-title: JAMA
  doi: 10.1001/jama.298.7.765
– volume: 62
  start-page: 7
  year: 2021
  ident: 3712_CR16
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.62.14.7
– year: 2022
  ident: 3712_CR33
  publication-title: Antioxidants
  doi: 10.3390/antiox11040617
– volume: 27
  start-page: 246
  year: 1990
  ident: 3712_CR47
  publication-title: Blood Vessels
– volume: 68
  start-page: 1108
  year: 2020
  ident: 3712_CR11
  publication-title: Indian J Ophthalmol
  doi: 10.4103/ijo.IJO_1398_19
– volume: 16
  start-page: 43
  year: 2016
  ident: 3712_CR21
  publication-title: BMC Ophthalmol
  doi: 10.1186/s12886-016-0217-1
– volume: 48
  start-page: 3805
  year: 2007
  ident: 3712_CR35
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.06-1280
– volume: 113
  start-page: 1488
  year: 2006
  ident: 3712_CR22
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2006.03.028
– volume: 29
  start-page: 111
  year: 2021
  ident: 3712_CR10
  publication-title: J Med Ultrasound
  doi: 10.4103/JMU.JMU_88_20
– volume: 39
  start-page: 1602
  year: 2018
  ident: 3712_CR13
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehx810
– volume: 1
  start-page: 718
  year: 2016
  ident: 3712_CR42
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2016.2049
SSID ssj0024549
Score 2.370854
Snippet Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms,...
Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological...
Abstract Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow,...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 512
SubjectTerms Acute coronary syndrome
Acute Coronary Syndrome - complications
Acute Coronary Syndrome - diagnostic imaging
Acute coronary syndromes
Angiography
Biomarkers
Blood flow
Cardiovascular disease
Care and treatment
Carotid artery
Comorbidity
Complications and side effects
Computational fluid dynamics
Computed tomography
Computed Tomography Angiography
Computer applications
Coronary Angiography - methods
Coronary Artery Disease
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetic retinopathy
Electronic health records
Finite volume method
Flow velocity
Fluid dynamics
Heart diseases
Hemodynamic monitoring
Hemodynamic numerical simulation
Hemodynamics
Hospitals
Humans
Ischemia
Medical examination
Medical records
Methods
Morphology
Numerical analysis
Observation methods
Ophthalmic artery
Ophthalmic Artery - diagnostic imaging
Patients
Prevention
Risk factors
Simulation
Simulation methods
Type 2 diabetes
Veins & arteries
Velocity
Viscosity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFH-MHsYuY93W1ms3NBj0UExtS7LkYzsWwqDbZYHehD5sEuic0DiH_fd9T7ZDzKC77GKCJYH19L7z3k8AX4Jy1Pit00Z6St24LLXS29SqotbSO5c7ynfc_SjnC_H9Xt4fXPVFNWE9PHBPuGsnq7KqQ5PnthDecicFWmzbONSswqnY5os2bwymRpQ9DHvGFhldXm_RqqFCoMp1gqjD58QMRbT-v3XygVGaFkweWKDZG3g9uI7spv_kY3hRt2_h5d3w5_g7WPzcLLulffi98ixWav5hfVvvlq1aRrlWVrAx18ooActsG-KP9a5j1u-6mnlCNLC4dIQyeA-L2bdfX-fpcGtC6mXJO3SXQ1C1tVIJ1F1O6Cy4TLkKXUGkGhdNofBEgrMVGvdSeRwJeeCqIRidCml7Akftuq3PgEndCMWrEJDAIohS59IKy3UmnERXySeQj0Q0foAUp5stHkwMLXRpesIbJLyJhDdZAlf7NZseUOPZ2bd0NvuZBIYdXyCLmIFFzL9YJIFLOllDIouf5-3QeYCbJPArc6MIty3TVZ7AxWQmipqfDo-8YQZR3xr0_xQGXRinJfB5P0wrqXytrde7OKeQnMDOEjjtWWm_JV5yjlZHJaAmTDbZ83SkXS0jEDgqT3Sv5If_QaRzeFWQfFDGXF7AUfe4qz-iv9W5T1G0ngDltiWQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9QwFH_oCuJF_La6SgTBg5Rtm6RJT7KKyyKsXhyYW8hH6wys7bjTOfjf-14mnd0i7GUokwT6kvfxy-vLLwDvg3J08FvnnfSUunFFbqW3uVVVq6V3rnSU77j4Xp8vxLelXKaE2zaVVU4-MTrqMHjKkZ9gmFWIbREOf9r8yenWKPq6mq7QuAv3iLqMtFotrzdcAjc_00EZXZ9sMbahW6D6dSKqw99ZMIqc_f975huhaV42eSMOnT2ChwlAstP9ij-GO23_BO5fpE_kT2HxY7MaV_by99qzWK_5l-0P927ZumeUcWUVmzKujNKwzPYhPgy7kVm_G1vmidfA4tCJ0OAZLM6-_vxynqe7E3Ivaz4iaA5BtdZKJdCDOaGL4ArlGgSEtnNcdJXCdQnONhjia-WxJZSBq47IdBrERM_hqB_69iUwqTuheBMCQgsRRK1LaYXluhBOImDyGZTTJBqfiMXpfotLEzcYujb7iTc48SZOvCky-HgYs9nTatza-zOtzaEnUWLHP4arXyZZmHGyqZs2dGVpK-Etd1KgGCgshmDhlM7gA62sIcPF1_M2nT9AIYkCy5wqYm8rdFNmcDzriQbn582Tbphk8FtzrZ4ZvDs000gqYuvbYRf7VJIT5VkGL_aqdBCJ15xj7FEZqJmSzWSet_TrVaQDRxeKIEu-uv21XsODijSfMuLyGI7Gq137BvHU6N5Go_kHVt4dJg
  priority: 102
  providerName: ProQuest
Title Ophthalmic artery changes in type 2 diabetes with and without acute coronary syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/36335387
https://www.proquest.com/docview/2737758182
https://www.proquest.com/docview/2732535703
https://pubmed.ncbi.nlm.nih.gov/PMC9636615
https://doaj.org/article/b5969edf11a24ca3b54623afb0124b78
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_uA8QX8dvquUQQfJDVfiRN-iByK3ccwp5yuLD4EvLR3i6s3XO3C95_70y2Xa94-ORLKE0CnclM5qPJbwBee2np4rcaVsJR6sbGQyOcGRqZlko4axNL-Y7xeX424Z-nYroHXbmjloHrW0M7qic1WS3e_fp5_REV_kNQeJW_X6PNQnWnc-kEQIftPhyiZZJU0WDM1R_sPQyGuoszt87rGaeA4f_3Tn3DVPWPUd6wS6f34V7rULLjrQQ8gL2yfgh3xu0v80cw-XI1a2Zm8WPuWDi_ec22l33XbF4zysCylHUZWEZpWWZqHx6Wm4YZt2lK5gjnwODUDuDgMUxOT759Ohu2tRSGTuRZg06097I0RkiOO5rlKvY2lrZAB9FUNuNVKnGdvDUFmvxcOuzxic9kReA6BfpIT-CgXtblM2BCVVxmhffoanDPc5UIw02mYm4FOlAugqRjonYt0DjVu1joEHCoXG8Zr5HxOjBexxG83c252sJs_HP0iNZmN5IgssOL5epStxqnrSjyovRVkpiUO5NZwZEMJBZNMrdSRfCGVlaTaOHnOdPeR0AiCRJLH0tCc4tVkURw1BuJCuj63Z1s6E5-NXqFEkMxjN4ieLXrppl0qK0ul5swJhUZQaBF8HQrSjuSsjzL0BbJCGRPyHo093vq-SzAg-OWik6XeP4_mPQC7qakH5RHF0dw0Kw25Uv0who7gH05lQM4HJ2cf70YhFzGIKgbthej778Br_IxwA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRQIuiHcDBYwE4oCiJrEdJweEyqPa0m65dKW9GT8SdqWSXbpZof4pfiMzeWwbIfXWSxTFtmSP5x3PZ4A3Xlkq_M7CUjpK3dgoNNKZ0KikyKSzNraU7xifpKOJ-DaV0y3429fC0LHKXic2itovHOXI99DMKvRt0R3-uPwd0q1R9He1v0KjZYuj4uIPhmyrD4dfcH_fJsnB19PPo7C7VSB0MuU1upPeq8IYqQTKthVZ5G2kbI6ukiktF2WicMbemhyNX6octvjYc1USzEyeEtABqvxbaHgjCvbU9DLAExhs9YU5Wbq3QluKaojOyxMwHj4Hxq-5I-B_S3DFFA6PaV6xewf34V7nsLL9lsMewFZRPYTb4-6X_COYfF_O6pk5-zV3rDkfesHaYuIVm1eMMrwsYX2Gl1Hal5nKNy-Ldc2MW9cFc4SjYHBoD6DwGCY3QtUnsF0tqmIHmMxKoXjuPboywos0i6URhmeRsBIdNBdA3BNRuw7InO7TONNNQJOluiW8RsLrhvA6CuD9ZsyyhfG4tvcn2ptNT4Lgbj4szn_qTqK1lXmaF76MY5MIZ7iVApeBi0WTL6zKAnhHO6tJUeD0nOnqHXCRBLml9xWhxUVZHgewO-iJAu6GzT1v6E7BrPSlOATwetNMI-nQXFUs1k2fRHKCWAvgactKmyXxlHO0dSoANWCywZqHLdV81sCPo8pGp04-u35ar-DO6HR8rI8PT46ew92EpICy8XIXtuvzdfECfbnavmwEiMGPm5bYfyAbWis
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ophthalmic+artery+changes+in+type+2+diabetes+with+and+without+acute+coronary+syndrome&rft.jtitle=Journal+of+translational+medicine&rft.au=Lan-ting+Wu&rft.au=Jia-lin+Wang&rft.au=Yan-ling+Wang&rft.date=2022-11-05&rft.pub=BMC&rft.eissn=1479-5876&rft.volume=20&rft.issue=1&rft.spage=1&rft.epage=10&rft_id=info:doi/10.1186%2Fs12967-022-03712-0&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b5969edf11a24ca3b54623afb0124b78
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon